Morningstar brands and products Company Portfolio ...

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced the advancement of two key ...

prefilled syringe autoinjector for the acute treatment of migraine with or without aura and cluster headache in adults. Second, Amneal has received approval from the FDA for exenatide, which is ...

In a separate development, Amneal received FDA approval for exenatide, which is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. This marks one ...